Jubraj Barry, Marvin Vanessa, Poots Alan J, Patel Shreena, Bovill Iñaki, Barnett Nina, Issen Laurel, Bell Derek
Pharmacy Department , Chelsea and Westminster Hospital NHS Foundation Trust , London , UK ; National Institute of Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care Northwest London (CLAHRC NWL) , London , UK.
Pharmacy Department , Chelsea and Westminster Hospital NHS Foundation Trust , London , UK ; Pharmacy Department , Chelsea and Westminster Hospital NHS Foundation Trust , London , UK.
Eur J Hosp Pharm. 2015 Jul;22(4):243-248. doi: 10.1136/ejhpharm-2015-000664. Epub 2015 Jun 3.
Our aim was to explore junior doctors' attitudes and awareness around concepts related to medication review, in order to find ways to change the culture for reviewing, altering and stopping inappropriate or unnecessary medicines. Having already demonstrated the value of team working with senior doctors and pharmacists and the use of a medication review tool, we are now looking to engage first year clinicians and undergraduates in the process.
An online survey about medication review was distributed among all 42 foundation year one (FY1) doctors at the Chelsea and Westminster Hospital NHS Foundation Trust in November 2014. Descriptive statistics were used for analysis.
Twenty doctors completed the survey (48%). Of those, 17 believed that it was the pharmacist's duty to review medicines; and 15 of 20 stated the general practitioner (GP). Sixteen of 20 stated that they would consult a senior doctor first before stopping medication. Eighteen of 20 considered the GP and consultant to be responsible for alterations, rather than themselves. Sixteen of 20 respondents were not aware of the availability of a medication review tool. Seventeen of 20 felt that more support from senior staff would help them become involved with medication review.
Junior doctors report feeling uncomfortable altering mediations without consulting a senior first. They appear to be building confidence with prescribing in their first year but not about the medication review process or questioning the drugs already prescribed. Consideration should be given to what we have termed a 'bottom-up' educational approach to provide early experience of and change the culture around medication review, to include the education of undergraduate and foundation doctors and pharmacists.
我们的目标是探讨初级医生对与药物审查相关概念的态度和认识,以便找到改变审查、更改和停用不适当或不必要药物的文化的方法。我们已经证明了与资深医生和药剂师团队合作以及使用药物审查工具的价值,现在我们希望让一年级临床医生和本科生参与到这个过程中。
2014年11月,在切尔西和威斯敏斯特医院国民保健服务信托基金对所有42名一年级基础医生(FY1)进行了一项关于药物审查的在线调查。采用描述性统计进行分析。
20名医生完成了调查(48%)。其中,17人认为审查药物是药剂师的职责;20人中有15人提到了全科医生(GP)。20人中有16人表示在停药前会首先咨询资深医生。20人中有18人认为更改药物是全科医生和顾问的责任,而不是他们自己。20名受访者中有16人不知道有药物审查工具。20人中有17人认为来自资深员工的更多支持将有助于他们参与药物审查。
初级医生报告说,在没有首先咨询资深医生的情况下更改药物会让他们感到不安。他们在第一年开处方时似乎正在建立信心,但在药物审查过程或质疑已开药物方面并非如此。应该考虑我们所说的“自下而上”的教育方法,以提供药物审查的早期经验并改变围绕药物审查的文化,包括对本科学生、基础医生和药剂师的教育。